TSHA

TSHA Stock-Based Compensation

$18.17MTTM · USD

Period ending:

TSHA FY Stock-Based CompUSD
TSHA FY Stock-Based Comp2019-12-31: $0.002020-12-31: $3.35M2021-12-31: $18.18M2022-12-31: $18.04M2023-12-31: $7.91M2024-12-31: $13.10M2025-12-31: $13.30M$18.18M$0.00
2019-12-312025-12-31

Source: Financial Modeling Prep (FMP). Annual fiscal periods; reported in USD. Dates are period ends; a fiscal year may differ from a calendar year.

TSHA stock-based compensation history

Non-cash compensation expense paid in equity. The available annual fiscal periods series contains 7 observations from Dec 31, 2019 to Dec 31, 2025.

Taysha Gene Therapies Inc Stock-Based Compensation — Annual fiscal periods (USD)
Period endingStock-Based Compensation (USD)
13,298,000
13,103,000
7,905,000
18,043,000
18,184,000
3,354,000
0

Compare stock-based compensation

All TSHA financial metrics · TSHA stock overview · How to interpret financial metrics

Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.